Exploring and challenging the network of angiogenesis

Raúl Montañez1, Francisca Sánchez-Jiménez, Ana R Quesada

  • 1Department of Molecular Biology and Biochemistry, Faculty of Science, University of Málaga, Spain.

Scientific Reports
|February 23, 2012
PubMed

Insights

Targeting cancer

Area of Science:

  • Oncology and Systems Biology

Background:

  • Angiogenesis, the formation of new blood vessels, is a critical hallmark of cancer.
  • Targeting angiogenesis is a key strategy in anticancer therapy.

Purpose of the Study:

  • To analyze the robustness and resilience of the angiogenic network using a systems approach.
  • To evaluate the effectiveness of targeted drug attacks on angiogenesis.

Main Methods:

  • A network-based theoretical approach was employed to model the angiogenic process.
  • Simulations were conducted to assess the impact of combined drug attacks on the network.

Main Results:

  • The angiogenic network, despite being disrupted by targeted attacks, largely maintained its overall function and efficiency.
  • Global patterns and local efficiency remained significantly unaltered post-attack, indicating high robustness.

Conclusions:

  • The angiogenic network exhibits significant robustness and resilience to targeted therapies.
  • Effective blockade of angiogenesis requires directed, combination therapies targeting multiple network components.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...